Skip to main content
Fig. 3 | Critical Care

Fig. 3

From: Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units

Fig. 3

Performance of BDG and PCT for the diagnosis of candidaemia over bacteraemia in the study population. The area under the ROC curve was 0.919 for (1,3)-β-d-glucan (BDG) (95% CI 0.875–0.962) and 0.789 for procalcitonin (PCT) (95% CI 0.720–0.856). The points on the curves with the maximum Youden Index were 113 pg/ml for BDG and 1.93 ng/ml for PCT. Diagnostic performances of the two markers used alone or combined are detailed in Tables 2 and 3, respectively

Back to article page